Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Clarke

Showing results (1241-1250 of 1,753) with videos related to

Pageof 176
Sort By:
The Journal of Biological Chemistry|January 24, 2007
Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosisGustavo H B Maegawa, Michael Tropak, Justin Buttner, et al.
American Journal of Medical Genetics. Part A|March 14, 2007
Late onset Leigh syndrome and ataxia due to a T to C mutation at bp 9,185 of mitochondrial DNAAvril E Castagna, Jane Addis, Roderick R McInnes, et al.
Biochemical and Biophysical Research Communications|December 15, 1992
The importance of arginine 102 for the substrate specificity of Escherichia coli malate dehydrogenaseD J Nicholls, J Miller, M D Scawen, et al.
Biochemistry|January 14, 1997
Is the structure of the N-domain of phosphoglycerate kinase affected by isolation from the intact molecule?L L Hosszu, C J Craven, J Spencer, et al.
Brain : a Journal of Neurology|December 13, 2002
Homocysteine and brain atrophy on MRI of non-demented elderlyT den Heijer, S E Vermeer, R Clarke, et al.
Neurology|November 13, 2002
Homocysteine and cognitive function in the elderly: the Rotterdam Scan StudyN D Prins, T Den Heijer, A Hofman, et al.
Australian Health Review : a Publication of the Australian Hospital Association|August 11, 2001
From efficacy to effectiveness: managing organisational change to improve health services for young people with deliberate self harm behaviourM J Tobin, A R Clarke, R Buss, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1995
Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblastsL Zitvogel, H Tahara, P D Robbins, et al.
Molecular Genetics and Metabolism|February 19, 2014
Outcomes of patients treated through the Canadian Fabry disease initiativeS M Sirrs, D G Bichet, R Casey, et al.
Biochemistry|September 24, 1991
Binding of a chaperonin to the folding intermediates of lactate dehydrogenaseI G Badcoe, C J Smith, S Wood, et al.
Pageof 176

Showing results (1241-1250 of 1,753) with videos related to

Sort By:
Pageof 176
The Journal of Biological Chemistry|January 24, 2007
Pyrimethamine as a potential pharmacological chaperone for late-onset forms of GM2 gangliosidosisGustavo H B Maegawa, Michael Tropak, Justin Buttner, et al.
American Journal of Medical Genetics. Part A|March 14, 2007
Late onset Leigh syndrome and ataxia due to a T to C mutation at bp 9,185 of mitochondrial DNAAvril E Castagna, Jane Addis, Roderick R McInnes, et al.
Biochemical and Biophysical Research Communications|December 15, 1992
The importance of arginine 102 for the substrate specificity of Escherichia coli malate dehydrogenaseD J Nicholls, J Miller, M D Scawen, et al.
Biochemistry|January 14, 1997
Is the structure of the N-domain of phosphoglycerate kinase affected by isolation from the intact molecule?L L Hosszu, C J Craven, J Spencer, et al.
Brain : a Journal of Neurology|December 13, 2002
Homocysteine and brain atrophy on MRI of non-demented elderlyT den Heijer, S E Vermeer, R Clarke, et al.
Neurology|November 13, 2002
Homocysteine and cognitive function in the elderly: the Rotterdam Scan StudyN D Prins, T Den Heijer, A Hofman, et al.
Australian Health Review : a Publication of the Australian Hospital Association|August 11, 2001
From efficacy to effectiveness: managing organisational change to improve health services for young people with deliberate self harm behaviourM J Tobin, A R Clarke, R Buss, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1995
Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblastsL Zitvogel, H Tahara, P D Robbins, et al.
Molecular Genetics and Metabolism|February 19, 2014
Outcomes of patients treated through the Canadian Fabry disease initiativeS M Sirrs, D G Bichet, R Casey, et al.
Biochemistry|September 24, 1991
Binding of a chaperonin to the folding intermediates of lactate dehydrogenaseI G Badcoe, C J Smith, S Wood, et al.
Pageof 176